Ovarian Cancer Research Foundation Highlights Importance of BRCA Testing and Early Detection
Ovarian Cancer Research Foundation (OCRF) shared a post on LinkedIn:
“Today is Inherited Cancers Awareness Day. We stand with our friends at Inherited Cancers Australia to encourage all Australians to know their cancer risk.
As the saying goes, prevention is better than cure, and knowing your risk might just save your life.
In the case of ovarian cancer approximately 15 – 25% of ovarian cancers have a genetic cause, with mutations in the BRCA1 or BRCA2 genes being the most common. Between 39 – 58% of women who inherit a harmful change in BRCA1, and 13 – 29% of women who inherit a harmful change in BRCA2, will develop ovarian cancer during their lifetime.
Genetic testing and surveillance allow individuals to manage their risk, detect cancer earlier, or prevent it altogether.
We also add our voice to the call for greater access to timely genetic counselling and testing and recognition of the lifelong support needs of families living with inherited cancer risk.
To find out more, visit the Inherited Cancers website or read about ovarian cancer risk.”
More posts featuring Ovarian Cancer Research Foundation on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023